Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Corcept Therapeutics Inc

NASDAQ: CORT · Life Sciences · 13 alerts · CIK 1088856

Share price
$69.22Close, Nov 16
Market cap
$7.58B
Shares outstanding
109.44MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Corcept Therapeutics Inc filings on SEC EDGAR ↗

8:15 AM ET 8-K
Leadership Change

Corcept Therapeutics Leadership Change

Sean Maduck, President of Corcept Endocrinology, is resigning effective October 1, 2026, and will be succeeded by Justin Gunn. Maduck will transition to a senior commercial advisor role under a consulting agreement paying $57,000 per month through September 2027.

Counterparty
Sean Maduck
Term
1 year

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.